Literature DB >> 20349244

Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice.

Ralf Köhler1, Peter Ruth.   

Abstract

K(+) channels are important regulators of arterial tone by providing membrane hyperpolarization and thus counteracting the activity of voltage-gated Ca(2+) channels in the smooth muscle and, thus, vasoconstriction. The endothelium and smooth muscle express a variety of different K(+) channels, such as Ca(2+)-activated K(+) channels (KCa), voltage-gated (KV), two-pore-domain (K2P), and inward rectifying (KIR) and KATP channels. Their contributions to the numerous mechanisms of endothelium-dependent and smooth muscle-dependent relaxation are closely related to their electrophysiological properties, activation mechanisms, and to differential expressions pattern within the vascular wall. Here, we summarize the cardiovascular phenotypes in murine models of genetic K(+)-channel deficiency and focus, in particular, on defective vasoregulation in mice deficient of endothelial Ca(2+)-activated K(+) channels, IK (KCa3.1) and SK (KCa2.3), and smooth muscle Ca(2+)-activated K(+) channels, BK (KCa.1.1). Genetic deficiency of endothelial IK and SK severely impairs the endothelium-derived hyperpolarization-mediated type of arterial dilation. Moreover, SK deficiency impairs NO-mediated dilator responses, thus indicating subtype-specific actions in endothelial function. Loss of IK and/or SK channels is associated with sizeable higher blood pressure. In contrast, genetic deficiency of smooth BK channels enhances arterial blood pressure which is linked to mainly a loss of spontaneous transient outward currents in the smooth muscle cells as well as renal and adrenal gland functions (hyperaldosteronism). In conclusion, genetic deficiency of vascular K(+) channels results in severe impairments of local and systemic blood pressure regulation. These alterations strengthen the perspective that vascular K(+) channels are potential pharmacologic targets for improvement of vasodilator functions in cardiovascular pathologies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349244     DOI: 10.1007/s00424-010-0819-z

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  49 in total

Review 1.  Ion channels and their functional role in vascular endothelium.

Authors:  B Nilius; G Droogmans
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

2.  Respiration and parturition affected by conditional overexpression of the Ca2+-activated K+ channel subunit, SK3.

Authors:  C T Bond; R Sprengel; J M Bissonnette; W A Kaufmann; D Pribnow; T Neelands; T Storck; M Baetscher; J Jerecic; J Maylie; H G Knaus; P H Seeburg; J P Adelman
Journal:  Science       Date:  2000-09-15       Impact factor: 47.728

3.  EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice.

Authors:  A Huang; D Sun; M A Carroll; H Jiang; C J Smith; J A Connetta; J R Falck; E G Shesely; A Koller; G Kaley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

Review 4.  International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels.

Authors:  Aguan D Wei; George A Gutman; Richard Aldrich; K George Chandy; Stephan Grissmer; Heike Wulff
Journal:  Pharmacol Rev       Date:  2005-12       Impact factor: 25.468

5.  The BK channel beta1 subunit gene is associated with human baroreflex and blood pressure regulation.

Authors:  Maik Gollasch; Jens Tank; Friedrich C Luft; Jens Jordan; Philipp Maass; Christine Krasko; Arya M Sharma; Andreas Busjahn; Sylvia Bähring
Journal:  J Hypertens       Date:  2002-05       Impact factor: 4.844

6.  Cytochrome P450 2C is an EDHF synthase in coronary arteries.

Authors:  B Fisslthaler; R Popp; L Kiss; M Potente; D R Harder; I Fleming; R Busse
Journal:  Nature       Date:  1999-09-30       Impact factor: 49.962

7.  Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension.

Authors:  José M Fernández-Fernández; Marta Tomás; Esther Vázquez; Patricio Orio; Ramón Latorre; Mariano Sentí; Jaume Marrugat; Miguel A Valverde
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 8.  Endothelium-derived hyperpolarizing factor: where are we now?

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-16       Impact factor: 8.311

9.  Relaxation of arterial smooth muscle by calcium sparks.

Authors:  M T Nelson; H Cheng; M Rubart; L F Santana; A D Bonev; H J Knot; W J Lederer
Journal:  Science       Date:  1995-10-27       Impact factor: 47.728

10.  Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries.

Authors:  Kim A Dora; Nicola T Gallagher; Alister McNeish; Christopher J Garland
Journal:  Circ Res       Date:  2008-04-10       Impact factor: 17.367

View more
  36 in total

Review 1.  A BK (Slo1) channel journey from molecule to physiology.

Authors:  Gustavo F Contreras; Karen Castillo; Nicolás Enrique; Willy Carrasquel-Ursulaez; Juan Pablo Castillo; Verónica Milesi; Alan Neely; Osvaldo Alvarez; Gonzalo Ferreira; Carlos González; Ramón Latorre
Journal:  Channels (Austin)       Date:  2013-09-11       Impact factor: 2.581

2.  Characteristics of ACh-induced hyperpolarization and relaxation in rabbit jugular vein.

Authors:  Takeo Itoh; Takashi Maekawa; Yasushi Shibayama
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

3.  Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.

Authors:  Ramesh C Mishra; Heike Wulff; Michael A Hill; Andrew P Braun
Journal:  J Cardiovasc Pharmacol       Date:  2015-07       Impact factor: 3.105

4.  Impaired β-adrenoceptor-induced relaxation in small mesenteric arteries from DOCA-salt hypertensive rats is due to reduced K(Ca) channel activity.

Authors:  Takayuki Matsumoto; Theodora Szasz; Rita C Tostes; R Clinton Webb
Journal:  Pharmacol Res       Date:  2012-02-21       Impact factor: 7.658

5.  Modulation of endothelial SK3 channel activity by Ca²+dependent caveolar trafficking.

Authors:  Mike T Lin; John P Adelman; James Maylie
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

6.  Dynamic coupling between TRPV4 and Ca2+-activated SK1/3 and IK1 K+ channels plays a critical role in regulating the K+-secretory BK channel in kidney collecting duct cells.

Authors:  Yue Li; Hongxiang Hu; Jin-Bin Tian; Michael X Zhu; Roger G O'Neil
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-08

7.  Inwardly rectifying K+ channels are major contributors to flow-induced vasodilatation in resistance arteries.

Authors:  Sang Joon Ahn; Ibra S Fancher; Jing-Tan Bian; Chong Xu Zhang; Sarah Schwab; Robert Gaffin; Shane A Phillips; Irena Levitan
Journal:  J Physiol       Date:  2016-12-26       Impact factor: 5.182

8.  Whole-exome sequencing reveals genetic variants associated with chronic kidney disease characterized by tubulointerstitial damages in North Central Region, Sri Lanka.

Authors:  Shanika Nanayakkara; S T M L D Senevirathna; Nipuna B Parahitiyawa; Tilak Abeysekera; Rohana Chandrajith; Neelakanthi Ratnatunga; Toshiaki Hitomi; Hatasu Kobayashi; Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2015-06-25       Impact factor: 3.674

9.  Endothelium-dependent hyperpolarization-related relaxations diminish with age in murine saphenous arteries of both sexes.

Authors:  Ramesh Chennupati; Wouter H Lamers; S Eleonore Koehler; Jo G R De Mey
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 10.  Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?

Authors:  Corina M Balut; Kirk L Hamilton; Daniel C Devor
Journal:  ChemMedChem       Date:  2012-08-07       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.